The other anti-inflammatory cytokines IL-4 and IL-13 were raised only in recovered post-COVID-19 patients (Fig. 2 H and I), whereas TGF-β1 remained unchanged in all cases (Fig. 2 J). This evidence concerns the gene TGFB1 and COVID-19.